COLL vs RUN
Collegium Pharmaceutical Inc (COLL) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the COLL and RUN stock pages for the full models.
Not investment advice.